BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 16963195)

  • 1. Psychosocial factors associated with the adherence to a colorectal cancer screening program.
    Gili M; Roca M; Ferrer V; Obrador A; Cabeza E
    Cancer Detect Prev; 2006; 30(4):354-60. PubMed ID: 16963195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer screening among Mexican Americans at a community clinic.
    Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
    Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer screening among first-degree relatives of colorectal cancer patients: benefits and barriers.
    Mack LA; Cook LS; Temple WJ; Carlson LE; Hilsden RJ; Paolucci EO
    Ann Surg Oncol; 2009 Aug; 16(8):2092-100. PubMed ID: 19479307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychological and behavioral factors associated with colorectal cancer screening among Ashkenazim.
    Friedman LC; Webb JA; Richards CS; Plon SE
    Prev Med; 1999 Aug; 29(2):119-25. PubMed ID: 10446038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do benefits and barriers differ by stage of adoption for colorectal cancer screening?
    Rawl SM; Menon U; Champion VL; May FE; Loehrer P; Hunter C; Azzouz F; Monahan PO; Skinner CS
    Health Educ Res; 2005 Apr; 20(2):137-48. PubMed ID: 15314036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
    Inadomi JM
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening compliance by medicine residents: perceived and actual.
    Zack DL; DiBaise JK; Quigley EM; Roy HK
    Am J Gastroenterol; 2001 Oct; 96(10):3004-8. PubMed ID: 11693339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk and reluctance: understanding impediments to colorectal cancer screening.
    Weitzman ER; Zapka J; Estabrook B; Goins KV
    Prev Med; 2001 Jun; 32(6):502-13. PubMed ID: 11394954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams.
    Zheng YF; Saito T; Takahashi M; Ishibashi T; Kai I
    BMC Public Health; 2006 Nov; 6():272. PubMed ID: 17083746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of women regarding factors affecting colorectal cancer screening compliance.
    Weinberg DS; Turner BJ; Wang H; Myers RE; Miller S
    Prev Med; 2004 Jun; 38(6):669-75. PubMed ID: 15193887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and knowledge of colorectal cancer and screening in Hong Kong: a population-based study.
    Wong BC; Chan AO; Wong WM; Hui WM; Kung HF; Lam SK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):41-6. PubMed ID: 16706810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there gender differences in colorectal cancer test use prevalence and correlates?
    McQueen A; Vernon SW; Meissner HI; Klabunde CN; Rakowski W
    Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):782-91. PubMed ID: 16614124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening: how to help patients comply.
    Goldsmith G; Chiaro C
    J Fam Pract; 2008 Jul; 57(7):E2-7. PubMed ID: 18625166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening among Latinos from U.S. cities along the Texas-Mexico border.
    Fernandez ME; Wippold R; Torres-Vigil I; Byrd T; Freeberg D; Bains Y; Guajardo J; Coughlin SS; Vernon SW
    Cancer Causes Control; 2008 Mar; 19(2):195-206. PubMed ID: 18038186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
    van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
    J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.